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Sterile Neutrophilic Folliculitis with Vasculopathy
in a Young Male Patient with Infective Endocarditis
Carl Barrick, DO, Naeha Gupta, DO, Richard McClain, MD, and Stephen Purcell, DO
Lehigh Valley Health Network, Allentown, PA

HISTORY OF PRESENT ILLNESS: The patient is a 34 year-old male.

He was admitted to the hospital with methicillin sensitive Staphylococcus aureus
(MSSA) infective endocarditis complicated by septic pulmonary emboli, cervical
osteomyelitis with soft tissue extension, bacteremia and acute kidney injury.
On hospital day four, the patient abruptly developed a follicular rash on bilateral
upper extremities. He denied any associated symptoms including itching, burning
or pain. He had a fever of 38.6 C.
MEDICAL/SURGICAL HISTORY: Hepatitis C, anemia, osteomyelitis,
intravenous drug abuse, opioid addiction
MEDICATIONS: Vancomycin, cefazolin, linezolid, triamcinolone 0.1% cream
CURRENT TREATMENT: Triamcinolone 0.1% cream twice daily, treatment
of MSSA endocarditis with vancomycin, cefazolin, linezolid, treatment of
AKI with dialysis
PHYSICAL EXAMINATION: On initial exam, pink to purple, some eroded,
papules on the bilateral distal upper extremities. Scattered, non-blanching, bright
pink macules on the distal lower extremities. Three days later, the lesions evolved
into larger, firm, pink, centrally umbilicated, semi-translucent papules with few
similar-appearing lesions on the bilateral lower extremities. Seven days later,
the lesions began to spontaneously involute, leaving pink, crusted papules
and macules without scars.
LABORATORY DATA: Blood culture positive for MSSA, C-reactive protein
119mg/L (<7.0), hemoglobin 9.9 g/dL (12.5-17), creatinine 2.91mg/dL (0.53-1.3),
hepatitis C virus RNA 8,830,000 IU/mL. HIV Ag/Ab, C3, C4, TSH, tissue culture,
wound culture, remaining CBC, CMP are negative or WNL.
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BIOPSY: Health Network Laboratories (S18-27413, 07/03/2018) Right Arm:

“Upper and mid dermal perivascular chronic inflammation and dense perivascular
and interstitial acute inflammation with background leukocytoclastic debris,
perivascular fibrin deposition with fibrinoid degeneration of the vessel walls,
subepidermal and intraepidermal vesicle formation with associated neutrophils and
some amount of epidermal necrosis concentrated around a central hair follicle.”

FIGURE 1: Punch biopsy of right arm: Hematoxylin and Eosin stain
at 4x magnification. Mid dermal and perivascular acute and chronic
inflammation concentrated around central hair follicle.

FIGURE 2: Punch biopsy of right arm: Hematoxylin and Eosin stain
at 20x magnification. Leukocytoclastic debris, perivascular fibrin
deposition with fibrinoid degeneration of vessel walls.

FIGURE 3: Right arm with firm,
pink, centrally umbilicated,
semi-translucent papules

DISCUSSION: Sterile neutrophilic folliculitis with vasculopathy is a distinctive

cutaneous pattern first described by Magro and Crowsen in 1998. This rare entity
is characterized by a constellation of histopathological findings, which consist of
neutrophilic or suppurative and granulomatous folliculitis in addition to a Sweet’slike vascular reaction or leukocytoclastic vasculitis. It is believed to be a reaction
pattern to underlying systemic diseases such as Behcet’s disease, reactive
arthritis, inflammatory bowel disease, hepatitis B, various connective tissue
diseases, and distant extracutaneous infections.
The association between sterile neutrophilic folliculitis with vasculopathy and an
underlying systemic disease is based on speculation. The exact etiology remains
unclear. The leading theory describes an aberrant humoral or cell-mediated immune
response to various endogenous or exogenous triggers in a predisposed host.
Lesions vary in clinical presentation and may appear as folliculitis, vasculitis, or
vesiculopustular or acneiform eruptions preferentially involving the trunk, lower
extremities, and upper extremities. Constitutional symptoms such as fever,
arthralgias, or malaise may accompany the lesions.
Histopathology reveals neutrophilic or suppurative and granulomatous folliculitis in
conjunction with either 1) perivascular and intramural neutrophilic infiltrate with
leukocytoclasia and erythrocyte extravasation, demonstrating a Sweet’s-like
vascular reaction or 2) fibrinoid necrosis of vessel wall erythrocyte extravasation,
demonstrating a leukocytoclastic vasculitis. Tissue cultures and special stains
reveal the absence of infectious pathogens.
The finding of sterile neutrophilic folliculitis with vasculopathy does not necessarily
indicate the need for an exhaustive systemic disease workup. However, an infectious
trigger or underlying systemic illness such as connective tissue disease, inflammatory
bowel disease, or Behcet’s disease should be considered. Treatment options have
not yet been elucidated, however management of the underlying condition is the
mainstay of treatment at this time.
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